Your Source for BioScience Venture Capital Data
  • OnBioVC NEWS:

    - OnBioVC Announces Beta Launch of Service
    - OnBioVC INDEX(TM) Updated thru DEC 2009
    - OnBioVC 2009 Year-in-Review, now available
    - OnBioVC 1Q10 Trend Analysis, coming soon
  • SEARCH THE OnBioVC DATABASE:

  • business strategy life science

Neomend (Irvine, CA) a commercial-stage developer of sealant and adhesion-prevemtion products focused on the application to visceral pleura for open thoracotomy, closed a $30M Series D financing. Participants include Clarus Ventures, Sanderling Ventures, Novo Ventures, Vivo Ventures and Prospect Venture Partners.

Spiracur (Redwood City, CA) and early-stage medical device company focused on wound healing, closed a $20.3M Series B financing. Participants include Kleiner Perkins Caufield & Byers, New Leaf Venture Partners and De Novo Ventures.

LifeBond (Israel) a commercial-stage developer of wound-closure and hemostasis biomaterials, closed a $8M Series B financing. Participants include Pitango Venture Capital, GlenRock Israel and The Zitelman Group.

Adhezion Biomedical (Myomissing, PA) an early-stage device company focused on the development differentiated cyanoacrylate-based surgical, wound management and infection prevention technologies closed a $2.1M Series A financing, bringing the round total to $5.3M. Participants include Liberty Venture Partners.

Cohera Medical (Pittsburgh, PA) developer of wound management products and surgical tissue adhesives, closed a $16.1M Series B financing. Participants include Bradford Capital Partners and Kern Whelan Capital.

Celleration (Eden Prairie, MN) development-stage medical device company focused on wound healing, closed a $30M Series D financing. Participants include Venture Investors, Heron Capital and Clarian Health Ventures.

Celleration (Eden Prairie, MN) commercial-stage medical device company focused on non-contact ultrasound device for wound care, closed a $25M Series D financing. Participants include Venture Investors, Upper Lake Growth Capital, Baird Venture Partners, Aavin Equity Advisors, Triathlon Medical Ventures and New Science Ventures.

Celleration (Eden Prairie, MN) developer of non-contact ultrasound devices for wound-care, closed a $25M Series D financing. Participants include Venture Investors, Upper Lake Growth Capital, Baird Venture Partners, Aavin Equity Advisors, Triathlon Medical Ventures and New Science Ventures.

Histogen (San Diego, CA) regenerative medicine company developing solutions based on the fibroblasts, closed a $5.4M Series A financing. Participants include Secure Medical, CellCeuticals Skin Care, and Leonard H. Lavin.

ArGentis Pharmaceuticals (Memphis, TN) development-stage biopharmaceutical company focused the development of autoimmunity and ophthalmology therapeutics, closed a $2.0M Series financing. Participants include Innova Memphis.

« Previous Entries  

to top of page...